Gujarat Terce Laboratories Ltd Share Price – BSE

Pharmaceuticals, Small Cap

Gujarat Terce Laboratories announced that the Annual General Meeting(AGM) of the company will be held on 21 August 2026.

Net profit of Gujarat Terce Laboratories reported to Rs 0.10 crore in the quarter ended March 2026 as against net loss of Rs 3.39 crore during the previous quarter ended March 2025. Sales declined 7.47% to Rs 11.40 crore in the quarter ended March 2026 as against Rs 12.32 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 2.20 crore in the year ended March 2026 as against net loss of Rs 0.98 crore during the previous year ended March 2025. Sales declined 5.44% to Rs 47.47 crore in the year ended March 2026 as against Rs 50.20 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on 27 May 2026.

Net profit of Gujarat Terce Laboratories declined 24.75% to Rs 0.76 crore in the quarter ended December 2025 as against Rs 1.01 crore during the previous quarter ended December 2024. Sales declined 3.08% to Rs 12.29 crore in the quarter ended December 2025 as against Rs 12.68 crore during the previous quarter ended December 2024.

Powered by Capital Market - Live News